
HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya
Author(s) -
Rami Kantor,
Allison DeLong,
Leeann Schreier,
Marissa B Reitsma,
Emanuel Kemboi,
Millicent Orido,
Salome Obonge,
Robert Boinett,
Mary Rono,
Wilfred Emonyi,
Katie R. Brooks,
Mia Coetzer,
Nathan Buziba,
Joseph W. Hogan,
Lameck Diero
Publication year - 2018
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000001964
Subject(s) - viral load , viremia , medicine , lopinavir , drug resistance , hiv drug resistance , regimen , immunology , human immunodeficiency virus (hiv) , biology , antiretroviral therapy , genetics
Characterize failure and resistance above and below guidelines-recommended 1000 copies/ml virologic threshold, upon second-line failure.